510(k) K210452
K210452 is an FDA 510(k) premarket notification submitted by Abbott Ireland Diagnostics Division for the device "Creatinine2". The FDA issued a decision of Substantially Equivalent on March 22, 2022. The device falls under product code CGX (Alkaline Picrate, Colorimetry, Creatinine), a Class II device regulated under 21 CFR 862.1225. Abbott Ireland Diagnostics Division has at least 7 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- March 22, 2022
- Date Received
- February 16, 2021
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Alkaline Picrate, Colorimetry, Creatinine
- Device Class
- Class II
- Regulation Number
- 862.1225
- Review Panel
- CH
- Submission Type